Columbia surgeons and radiation oncologists deliver precise radiotherapy immediately following cancer tumor removal.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.
New way to classify gum disease may allow for earlier detection of severe cases before loss of teeth and bone occurs.
Using stem cells from patients, P&S researchers have created a model of age-related macular degeneration in a dish, which may lead personalized treatments to prevent vision loss.